Heartflow, Inc. earnings releases HTFL

Annual Quarterly

Heartflow, Inc. last reported quarterly results on Aug 13, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $64.1 million (+47.6% year over year) and diluted EPS of -$0.18. It usually reports 43–72 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 11, 2026.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 43–72 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Aug 13, 2026
44 days after quarter end
Q2 FY2026
ended Jun 30, 2026
64
+47.6%
-16
-71.2%
-0.18
+87.7%
May 14, 2026
44 days after quarter end
Q1 FY2026
ended Mar 31, 2026
53
-27
-0.32
Nov 12, 2025
43 days after quarter end
Q3 FY2025
ended Sep 30, 2025
46
-51
-1.04
Sep 10, 2025
72 days after quarter end
Q2 FY2025
ended Jun 30, 2025
43
-9
-1.46

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
HTFL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Francisco, CA
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1464521
Former names
Cardiovascular Simulation, Inc. (until Jun 14, 2010)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.